We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

25 hedge funds and large institutions have $3.94M invested in OncoSec Medical Incorporated in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

108% more capital invested

Capital invested by funds: $1.89M → $3.94M (+$2.05M)

56% more funds holding

Funds holding: 16 → 25 (+9)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

Holders
25
Holders Change
+9
Holders Change %
+56.25%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$253K
2
Two Sigma Investments
Two Sigma Investments
New York
+$200K
3
Renaissance Technologies
Renaissance Technologies
New York
+$169K
4
SSA
Schonfeld Strategic Advisors
New York
+$98.9K
5
Goldman Sachs
Goldman Sachs
New York
+$64.5K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$86.1K
2
Citadel Advisors
Citadel Advisors
Florida
-$46.2K
3
Squarepoint
Squarepoint
New York
-$38K
4
SPC
Sigma Planning Corp
Michigan
-$14.2K
5
Bank of America
Bank of America
North Carolina
-$156

ONCS Hedge Fund Activity: Q3 2020 in Review

25 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2020, worth a combined $3.94M — up 108% from $1.89M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ONCS positions and 1 closed out — a net gain of 9 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $253K. The largest seller was BlackRock, cutting an estimated $86.1K.

  • 25 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2020, up from 16 in Q2 2020.
  • Funds reported $3.94M of OncoSec Medical Incorporated stock for Q3 2020, up 108% quarter-over-quarter.
  • 10 funds opened new OncoSec Medical Incorporated positions in Q3 2020 and 1 closed out, a net change of +9 holders.
  • The largest OncoSec Medical Incorporated buyer in Q3 2020 was Vanguard Group, an estimated $253K added.
  • The largest OncoSec Medical Incorporated seller in Q3 2020 was BlackRock, an estimated $86.1K sold.

Based on aggregated 13F filings for Q3 2020.